1. Home
  2. JANX vs TALK Comparison

JANX vs TALK Comparison

Compare JANX & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$13.59

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Logo Talkspace Inc.

TALK

Talkspace Inc.

HOLD

Current Price

$4.93

Market Cap

656.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JANX
TALK
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
790.3M
656.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
JANX
TALK
Price
$13.59
$4.93
Analyst Decision
Buy
Strong Buy
Analyst Count
12
5
Target Price
$52.45
$5.90
AVG Volume (30 Days)
1.0M
1.7M
Earning Date
06-01-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,000,000.00
N/A
Revenue This Year
N/A
$24.10
Revenue Next Year
$235.70
$18.15
P/E Ratio
N/A
$155.55
Revenue Growth
N/A
N/A
52 Week Low
$12.12
$2.22
52 Week High
$35.34
$5.18

Technical Indicators

Market Signals
Indicator
JANX
TALK
Relative Strength Index (RSI) 45.87 68.25
Support Level $13.03 $2.52
Resistance Level $13.79 $5.18
Average True Range (ATR) 0.50 0.29
MACD 0.14 0.07
Stochastic Oscillator 55.56 84.33

Price Performance

Historical Comparison
JANX
TALK

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: